{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-24-000129","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2024-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.338017+00:00","generated_at":"2026-05-30T12:18:37.643335+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pacira BioSciences appoints Shawn Cross as CFO effective Oct 21, 2024","bullets":["Shawn Cross appointed CFO effective Oct 21, 2024; succeeds interim CFO Lauren Riker, who remains SVP of Finance.","Cross brings >25 years of biopharma experience; former CEO/President/CFO of Applied Molecular Transport.","Annual base salary $525K; annual bonus target 50% of base; inducement awards of 200K stock options and 75K RSUs.","Inducement awards vest over four years; option exercise price equals Nov 4, 2024 closing price."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-24-000129","json":"https://secwatch.observer/filing/0001396814-24-000129.json","markdown":"https://secwatch.observer/filing/0001396814-24-000129.md","text":"https://secwatch.observer/filing/0001396814-24-000129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/pcrx-20241016.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:18:37.643335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4997efb191","claim":"Lauren Riker changed role as Senior Vice President of Finance at Pacira BioSciences, Inc..","evidence_excerpt":"Mr. Cross will succeed Lauren Riker, who had been serving as interim Chief Financial Officer since October 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"succeeded"},{"label":"Role","value":"Senior Vice President of Finance"}]},{"claim_id":"6b07119af2","claim":"Shawn M. Cross was appointed as Chief Financial Officer at Pacira BioSciences, Inc..","evidence_excerpt":"appointed Shawn M. Cross to serve as the Chief Financial Officer of the Company, effective October 21, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}